Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2014 Financial Results and Recent Events

Menlo Park, Calif., February 26, 2015 - Geron Corporation GERN will announce its financial results for the fourth quarter and year ended December 31, 2014, on Tuesday, March 3, 2015, after the market close. Geron's management will also host a conference call for analysts and investors on Tuesday, March 3, 2015, at 4:30 p.m. Eastern Time to discuss the company's fourth quarter and annual results and recent events.
Participants can access the conference call live via telephone by dialing (877) 703-6107 (U.S.); (857) 244-7306 (international). The passcode is 28650149. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/bu63s9fe/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through April 3, 2015.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Kevin Eng, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

###